COL1A1 and osteogenesis imperfecta: The vast majority of patients with OI (90%) have a point mutation in one of two genes: COL1A1 or COL1A2. These genes code for protein constituents of type 1 pro-collagen (proa1 and proa2 chains respectively) (3).